255 related articles for article (PubMed ID: 36706775)
21. Mixed-methods evaluation of point-of-care hepatitis C virus RNA testing in a Scottish prison.
Byrne CJ; Malaguti A; Inglis SK; Dillon JF
BMJ Open; 2023 Apr; 13(4):e068604. PubMed ID: 37037621
[TBL] [Abstract][Full Text] [Related]
22. The clinical effect of point-of-care HIV diagnosis in infants: a systematic review and meta-analysis.
Luo R; Fong Y; Boeras D; Jani I; Vojnov L
Lancet; 2022 Sep; 400(10356):887-895. PubMed ID: 36116479
[TBL] [Abstract][Full Text] [Related]
23. Point-of-Care International Normalized Ratio (INR) Monitoring Devices for Patients on Long-term Oral Anticoagulation Therapy: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(12):1-114. PubMed ID: 23074516
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the Xpert HCV VL Fingerstick point-of-care assay and dried blood spot HCV-RNA testing as simplified diagnostic strategies among people who inject drugs in Catalonia, Spain.
Saludes V; Antuori A; Lazarus JV; Folch C; González-Gómez S; González N; Ibáñez N; Colom J; Matas L; Casabona J; Martró E
Int J Drug Policy; 2020 Jun; 80():102734. PubMed ID: 32470849
[TBL] [Abstract][Full Text] [Related]
25. Point-of-care tests detecting HIV nucleic acids for diagnosis of HIV-1 or HIV-2 infection in infants and children aged 18 months or less.
Ochodo EA; Guleid F; Deeks JJ; Mallett S
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD013207. PubMed ID: 34383961
[TBL] [Abstract][Full Text] [Related]
26. Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade.
Bregenzer A; Conen A; Knuchel J; Friedl A; Eigenmann F; Näf M; Ackle P; Roth M; Fux CA
Swiss Med Wkly; 2017; 147():w14544. PubMed ID: 29185250
[TBL] [Abstract][Full Text] [Related]
27. Assessing the potential cost-effectiveness of centralised versus point-of-care testing for hepatitis C virus in Pakistan: a model-based comparison.
Babigumira JB; Karichu JK; Clark S; Cheng MM; Garrison LP; Maniecki MB; Hamid SS
BMJ Open; 2023 May; 13(5):e066770. PubMed ID: 37142306
[TBL] [Abstract][Full Text] [Related]
28. Household point of care CD4 testing and isoniazid preventive therapy initiation in a household TB contact tracing programme in two districts of South Africa.
Page-Shipp L; Lewis JJ; Velen K; Senoge S; Zishiri E; Popane F; Chihota VN; Clark D; Churchyard GJ; Charalambous S
PLoS One; 2018; 13(3):e0192089. PubMed ID: 29499060
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort study.
Grebely J; Lamoury FMJ; Hajarizadeh B; Mowat Y; Marshall AD; Bajis S; Marks P; Amin J; Smith J; Edwards M; Gorton C; Ezard N; Persing D; Kleman M; Cunningham P; Catlett B; Dore GJ; Applegate TL;
Lancet Gastroenterol Hepatol; 2017 Jul; 2(7):514-520. PubMed ID: 28442271
[TBL] [Abstract][Full Text] [Related]
30. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological interventions for acute hepatitis C infection.
Kalafateli M; Buzzetti E; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011644. PubMed ID: 30521693
[TBL] [Abstract][Full Text] [Related]
32. Risk of hepatitis C reinfection following successful therapy among people living with HIV: a global systematic review, meta-analysis, and meta-regression.
Hosseini-Hooshyar S; Hajarizadeh B; Bajis S; Law M; Janjua NZ; Fierer DS; Chromy D; Rockstroh JK; Martin TCS; Ingiliz P; Hung CC; Dore GJ; Martinello M; Matthews GV
Lancet HIV; 2022 Jun; 9(6):e414-e427. PubMed ID: 35659336
[TBL] [Abstract][Full Text] [Related]
33. Peer-delivered point-of-care testing and linkage to treatment for hepatitis C virus infection among marginalized populations through a mobile clinic in Copenhagen, Denmark.
Demant J; Krohn-Dehli L; Van der Veen J; Øvrehus A; Lazarus JV; Weis N
Int J Drug Policy; 2023 Nov; 121():104185. PubMed ID: 37774576
[TBL] [Abstract][Full Text] [Related]
34. Model-based cost-effectiveness estimates of testing strategies for diagnosing hepatitis C virus infection in people who use injecting drugs in Senegal.
Duchesne L; Hejblum G; Toure Kane NC; Njouom R; Toni TD; Moh R; Sylla B; Rouveau N; Attia A; Lacombe K
Int J Drug Policy; 2020 Jan; 75():102613. PubMed ID: 31786434
[TBL] [Abstract][Full Text] [Related]
35. Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia.
Bajis S; Maher L; Treloar C; Hajarizadeh B; Lamoury FMJ; Mowat Y; Schulz M; Marshall AD; Cunningham EB; Cock V; Ezard N; Gorton C; Hayllar J; Smith J; Whelan M; Martinello M; Applegate TL; Dore GJ; Grebely J;
Int J Drug Policy; 2018 Nov; 61():23-30. PubMed ID: 30388566
[TBL] [Abstract][Full Text] [Related]
36. The effect of introducing point-of-care or dried blood spot analysis on the uptake of hepatitis C virus testing in high-risk populations: A systematic review of the literature.
Coats JT; Dillon JF
Int J Drug Policy; 2015 Nov; 26(11):1050-5. PubMed ID: 26118799
[TBL] [Abstract][Full Text] [Related]
37. Point-of-care viral load testing among adolescents and youth living with HIV in Haiti: a protocol for a randomised trial to evaluate implementation and effect.
Reif LK; Belizaire ME; Seo G; Rouzier V; Severe P; Joseph JM; Joseph B; Apollon S; Abrams EJ; Arpadi SM; Elul B; Pape JW; McNairy ML; Fitzgerald DW; Kuhn L
BMJ Open; 2020 Aug; 10(8):e036147. PubMed ID: 32868354
[TBL] [Abstract][Full Text] [Related]
38. Improving Linkage to Care of Hepatitis C: Clinical Validation of GeneXpert® HCV Viral Load Point-of-Care Assay in Indonesia.
Thedja MD; Wibowo DP; El-Khobar KE; Ie SI; Turyadi ; Setiawan L; Murti IS; Muljono DH
Am J Trop Med Hyg; 2021 May; 105(1):117-124. PubMed ID: 33999849
[TBL] [Abstract][Full Text] [Related]
39. Reducing barriers to the hepatitis C care cascade in prison via point-of-care RNA testing: a qualitative exploration of men in prison using an integrated framework.
Lafferty L; Sheehan Y; Cochrane A; Grebely J; Lloyd AR; Treloar C
Addiction; 2023 Jun; 118(6):1153-1160. PubMed ID: 36683132
[TBL] [Abstract][Full Text] [Related]
40. Clinical Outcomes in a Randomized Controlled Trial Comparing Point-of-Care With Standard Human Immunodeficiency Virus (HIV) Viral Load Monitoring in Nigeria.
Chang C; Agbaji O; Mitruka K; Olatunde B; Sule H; Dajel T; Zee A; Ahmed ML; Ahmed I; Okonkwo P; Chaplin B; Kanki P
Clin Infect Dis; 2023 Feb; 76(3):e681-e691. PubMed ID: 35867672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
